EP1367968A4 — Applicator and methods for placing a trabecular shunt for glaucoma treatment
Assigned to Glaukos Corp · Expires 2006-12-13 · 19y expired
What this patent protects
Disclosed are an apparatus (2) and method for placing a fluid shunt (10), for the treatment of glaucoma, from inside the anterior chamber of an eye, through the trabecular meshwork, and into Schlemm's canal. The apparatus (2) can include a handpiece (14) having a distal end and a…
USPTO Abstract
Disclosed are an apparatus (2) and method for placing a fluid shunt (10), for the treatment of glaucoma, from inside the anterior chamber of an eye, through the trabecular meshwork, and into Schlemm's canal. The apparatus (2) can include a handpiece (14) having a distal end and a proximal end, an elongated tip connected to the distal end of the endpiece (14), the elongated tip having a distal portion and being configured to be placed through a corneal incision and into an anterior chamber of the eye; a holder (2, 20, 24) attached to the trabecular shunt (10); and an actuator (30, 32, 38) on the handpiece that actuates the holder (8, 20, 24) to release the inlet section of the trabecular shunt (10) from the holder.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.